1. Home /
  2. Pharmaceuticals

Pharmaceuticals

Deciphera Soars on Positive Phase III Drug Trial

Deciphera Soars on Positive Phase III Drug Trial

Deciphera Pharma stock more than doubled on positive results from a Phase III clinical study of its drug to treat patients with advanced gastrointestinal stromal tumors.

Earnings to Tell Whether Cannabis' High Growth Story Is Going to Pot

Earnings to Tell Whether Cannabis' High Growth Story Is Going to Pot

After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.

Evolus Could See Breakout Soon

Evolus Could See Breakout Soon

EOLS appears to have formed a small triangle pattern the past few weeks and a breakout is likely before reaching the apex.

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

Agency has the authority to carve out an exception to existing laws.

Fear Not the Curve, Sizing Up Earnings and Ways to Play Amgen: Market Recon

Fear Not the Curve, Sizing Up Earnings and Ways to Play Amgen: Market Recon

Understanding yourself and the investing environment you are in are keys to avoiding panic brought on by fear.

Nektar Therapeutics Drops Sharply for Second Day After Admitting Batch Issues

Nektar Therapeutics Drops Sharply for Second Day After Admitting Batch Issues

Nektar dropped 40% on Friday after announcing it had manufacturing issues in two batches of experimental cancer drugs.

Checking In on 2 Small Biotech Names That Had Big Quarters

Checking In on 2 Small Biotech Names That Had Big Quarters

Stemline Therapeutics and Flexion Therapeutics both saw their shares climb on positive news developments.

Is Cannabis Legislation Closer Than You Think?

Is Cannabis Legislation Closer Than You Think?

Common sense should prevail when it comes to legislation, according to this cannabis executive.

An Example of How I Stalk a Trade

An Example of How I Stalk a Trade

With Aurinia Pharmaceuticals, the key is to be patient and to buy incrementally.

Nektar Therapeutics Sinks on Cancer Treatment Manufacturing Issues

Nektar Therapeutics Sinks on Cancer Treatment Manufacturing Issues

Nektar says there have been manufacturing issues in two batches of experimental cancer drugs.